Search research articles
Contact Us
Filters
Showing results (51-60 of 115) with videos related to
Page
of 12
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology
|
November 9, 2000
Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells
Y Otake, A L Nolan, U K Walle, et al.
Research Communications in Chemical Pathology and Pharmacology
|
November 1, 1981
Chemical trapping of labile aldehyde intermediates in the metabolism of propranolol and oxprenolol
F Goldszer, G L Tindell, U K Walle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 1, 1995
Taxol metabolism and disposition in cancer patients
T Walle, U K Walle, G N Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2000
Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2
R A Walgren, K J Karnaky, G E Lindenmayer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2000
Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1
R A Walgren, J T Lin, R K Kinne, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1993
Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells
T Walle, U K Walle, K R Thornburg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1982
New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation
T Walle, J E Oatis, U K Walle, et al.
British Journal of Clinical Pharmacology
|
September 1, 1986
Partial metabolic clearances as determinants of the oral bioavailability of propranolol
T Walle, U K Walle, L S Olanoff, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1983
Stereoselective increase in propranolol bioavailability during chronic dosing in the dog
S A Bai, M J Wilson, U K Walle, et al.
Research Communications in Molecular Pathology and Pharmacology
|
August 10, 1999
Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2
U K Walle, K L French, R A Walgren, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 115) with videos related to
Sort By:
Page
of 12
The Journal of Steroid Biochemistry and Molecular Biology
|
November 9, 2000
Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells
Y Otake, A L Nolan, U K Walle, et al.
Research Communications in Chemical Pathology and Pharmacology
|
November 1, 1981
Chemical trapping of labile aldehyde intermediates in the metabolism of propranolol and oxprenolol
F Goldszer, G L Tindell, U K Walle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 1, 1995
Taxol metabolism and disposition in cancer patients
T Walle, U K Walle, G N Kumar, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2000
Efflux of dietary flavonoid quercetin 4'-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2
R A Walgren, K J Karnaky, G E Lindenmayer, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2000
Cellular uptake of dietary flavonoid quercetin 4'-beta-glucoside by sodium-dependent glucose transporter SGLT1
R A Walgren, J T Lin, R K Kinne, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 1993
Stereoselective sulfation of albuterol in humans. Biosynthesis of the sulfate conjugate by HEP G2 cells
T Walle, U K Walle, K R Thornburg, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1982
New ring-hydroxylated metabolites of propranolol: species differences and stereospecific 7-hydroxylation
T Walle, J E Oatis, U K Walle, et al.
British Journal of Clinical Pharmacology
|
September 1, 1986
Partial metabolic clearances as determinants of the oral bioavailability of propranolol
T Walle, U K Walle, L S Olanoff, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 1, 1983
Stereoselective increase in propranolol bioavailability during chronic dosing in the dog
S A Bai, M J Wilson, U K Walle, et al.
Research Communications in Molecular Pathology and Pharmacology
|
August 10, 1999
Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2
U K Walle, K L French, R A Walgren, et al.
Page
of 12